Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis (original) (raw)

Nature Genetics volume 34, pages 97–101 (2003)Cite this article

Abstract

Hereditary hemochromatosis is a prevalent genetic disorder of iron hyperabsorption leading to hyperferremia, tissue iron deposition and complications including cirrhosis, hepatocarcinoma, cardiomyopathy and diabetes. Most individuals affected with hereditary hemochromatosis are homozygous with respect to a missense mutation that disrupts the conformation of HFE, an atypical HLA class I molecule (ref. 1; OMIM 235200). Mice lacking Hfe2,3,4 or producing a C282Y mutant Hfe protein3 develop hyperferremia and have high hepatic iron levels. In both humans and mice, hereditary hemochromatosis is associated with a paucity of iron in reticuloendothelial cells. It has been suggested that HFE modulates uptake of transferrin-bound iron by undifferentiated intestinal crypt cells, thereby programming the absorptive capacity of enterocytes derived from these cells5,6; however, this model is unproven and controversial7,8. Hepcidin, a peptide hormone (HAMP; OMIM 606464), seems to act in the same regulatory pathway as HFE. Although expression of mouse Hamp is normally greater during iron overload, Hfe −/− mice have inappropriately low expression of Hamp. We crossed Hfe −/− mice with transgenic mice overexpressing Hamp and found that Hamp inhibited the iron accumulation normally observed in the Hfe −/− mice. This argues against the crypt programming model and suggests that failure of Hamp induction contributes to the pathogenesis of hemochromatosis, providing a rationale for the use of HAMP in the treatment of this disease.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 12 print issues and online access

195,33 € per year

only 16,28 € per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

References

  1. Feder, J.N. et al. A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosis. Nat. Genet. 13, 399–408 (1996).
    Article CAS PubMed Google Scholar
  2. Zhou, X.Y. et al. HFE gene knockout produces mouse model of hereditary hemochromatosis. Proc. Natl. Acad. Sci. USA 95, 2492–2497 (1998).
    Article CAS PubMed PubMed Central Google Scholar
  3. Levy, J.E., Montross, L.K., Cohen, D.E., Fleming, M.D. & Andrews, N.C. The C282Y mutation causing hereditary hemochromatosis does not produce a null allele. Blood 94, 9–11 (1999).
    CAS PubMed Google Scholar
  4. Bahram, S. et al. Experimental hemochromatosis due to MHC class I HFE deficiency: immune status and iron metabolism. Proc. Natl. Acad. Sci. USA 96, 13312–13317 (1999).
    Article CAS PubMed PubMed Central Google Scholar
  5. Roy, C.N. & Enns, C.A. Iron homeostasis: new tales from the crypt. Blood 96, 4020–4027 (2000).
    CAS PubMed Google Scholar
  6. Trinder, D., Olynyk, J.K., Sly, W.S. & Morgan, E.H. Iron uptake from plasma transferrin by the duodenum is impaired in the Hfe knockout mouse. Proc. Natl. Acad. Sci. USA 99, 5622–5626 (2002).
    Article CAS PubMed PubMed Central Google Scholar
  7. Townsend, A. & Drakesmith, H. Role of HFE in iron metabolism, hereditary haemochromatosis, anaemia of chronic disease, and secondary iron overload. Lancet 359, 786–790 (2002).
    Article CAS PubMed Google Scholar
  8. Drakesmith, H. et al. The hemochromatosis protein HFE inhibits iron export from macrophages. Proc. Natl. Acad. Sci. USA 99, 15602–15607 (2002).
    Article CAS PubMed PubMed Central Google Scholar
  9. Finch, C. Regulators of iron balance in humans. Blood 84, 1697–1702 (1994).
    CAS PubMed Google Scholar
  10. Krause, A. et al. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett. 480, 147–150 (2000).
    Article CAS PubMed Google Scholar
  11. Pigeon, C. et al. A new mouse liver specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J. Biol. Chem. 276, 7811–7819 (2001).
    Article CAS PubMed Google Scholar
  12. Park, C.H., Valore, E.V., Waring, A.J. & Ganz, T. Hepcidin: a urinary antimicrobial peptide synthesized in the liver. J. Biol. Chem. 276, 7806–7810 (2001).
    Article CAS PubMed Google Scholar
  13. Nicolas, G. et al. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc. Natl. Acad. Sci. USA 98, 8780–8785 (2001).
    Article CAS PubMed PubMed Central Google Scholar
  14. Roetto, A. et al. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat. Genet. 33, 21–22 (2003).
    Article CAS PubMed Google Scholar
  15. Nicolas, G. et al. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc. Natl. Acad. Sci. USA 99, 4596–4601 (2002).
    Article CAS PubMed PubMed Central Google Scholar
  16. Nicolas, G. et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J. Clin. Invest. 110, 1037–1044 (2002).
    Article CAS PubMed PubMed Central Google Scholar
  17. Weinstein, D.A. et al. Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood 100, 3776–3781 (2002).
    Article CAS PubMed Google Scholar
  18. Nemeth, E. et al. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 101, 2461–2463 (2003).
    Article CAS PubMed Google Scholar
  19. Ajioka, R.S., Levy, J.E., Andrews, N.C. & Kushner, J.P. Regulation of iron absorption in Hfe mutant mice. Blood 100, 1465–1469 (2002).
    Article CAS PubMed Google Scholar
  20. Ahmad, K.A. et al. Decreased liver hepcidin expression in the hfe knockout mouse. Blood Cells Mol. Dis. 29, 361–366 (2002).
    Article CAS PubMed Google Scholar
  21. Bridle, K.R. et al. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet 361, 669–673 (2003).
    Article CAS PubMed Google Scholar
  22. Courselaud, B. et al. C/EBPα regulates hepatic transcription of hepcidin, an antimicrobial peptide and regulator of iron metabolism. Cross-talk between C/EBP pathway and iron metabolism. J. Biol. Chem. 277, 41163–41170 (2002).
    Article CAS PubMed Google Scholar
  23. Yan, C., Costa, R.H., Darnell, J.E. Jr., Chen, J.D. & Van Dyke, T.A. Distinct positive and negative elements control the limited hepatocyte and choroid plexus expression of transthyretin in transgenic mice. EMBO J. 9, 869–878 (1990).
    Article CAS PubMed PubMed Central Google Scholar
  24. Torrance, J.D. & Bothwell, T.H. Tissue iron stores. Methods Hematol. 1, 90–115 (1980).
    CAS Google Scholar

Download references

Acknowledgements

We thank B. Grandchamp for discussions, J. Bauchet and N. Sorhaindo for technical assistance and L. Montross for maintaining and shipping Hfe−/− mice. This work was supported by the Institut National de la Sante et de la Recherche Medicale, the Ministère de la Recherche, the Howard Hughes Medical Institute and the US National Institutes of Health. G.N. was funded by the Fondation pour la Recherche Médicale and the Association Hémochromatose France.

Author information

Author notes

  1. Gaël Nicolas and Lydie Viatte: These authors contributed equally to this work.

Authors and Affiliations

  1. Département de Génétique, Développement et Pathologie Moléculaire, Institut Cochin, Institut National de la Santé et de la Recherche Médicale, Centre National de la Recherche Scientifique, et Université René Descartes, Faculté de Médecine Cochin-Port Royal, 24, rue du Fg St Jacques, Paris, 75014, France
    Gaël Nicolas, Lydie Viatte, Dan-Qing Lou, Myriam Bennoun, Axel Kahn & Sophie Vaulont
  2. Institut National de la Santé et de la Recherche Médicale 409, Faculté de Médecine Xavier Bichat, Paris, 75018, France
    Carole Beaumont
  3. Howard Hughes Medical Institute, Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA
    Nancy C. Andrews

Authors

  1. Gaël Nicolas
    You can also search for this author inPubMed Google Scholar
  2. Lydie Viatte
    You can also search for this author inPubMed Google Scholar
  3. Dan-Qing Lou
    You can also search for this author inPubMed Google Scholar
  4. Myriam Bennoun
    You can also search for this author inPubMed Google Scholar
  5. Carole Beaumont
    You can also search for this author inPubMed Google Scholar
  6. Axel Kahn
    You can also search for this author inPubMed Google Scholar
  7. Nancy C. Andrews
    You can also search for this author inPubMed Google Scholar
  8. Sophie Vaulont
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toSophie Vaulont.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

About this article

Cite this article

Nicolas, G., Viatte, L., Lou, DQ. et al. Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis.Nat Genet 34, 97–101 (2003). https://doi.org/10.1038/ng1150

Download citation

This article is cited by